Clinical

Treatment options for COVID-19: Dr. Annie Luetkemeyer


 

Annie Luetkemeyer, MD, professor of infectious diseases at UCSF, is an expert on the treatment of viral infections. Robert Wachter, MD, MHM, chair of the UCSF Department of Medicine, interviewed her about the evidence behind potential treatments for COVID-19 (including chloroquine/hydroxychloroquine, remdesivir, and others), as well as how to assess new and existing drugs in a pandemic.

Recommended Reading

How long is it safe to delay gynecologic cancer surgery?
Covid ICYMI
CDC coronavirus testing decision likely to haunt nation for months to come
Covid ICYMI
High rate of asymptomatic COVID-19 seen in cruise ship passengers
Covid ICYMI
Reports increasingly suggest anosmia/hyposmia can signal early COVID-19 infection
Covid ICYMI
Three COVID-19 rapid diagnostic tests get FDA thumbs-up
Covid ICYMI
COVID-19 critical care guideline offers support for frontline clinicians
Covid ICYMI
FDA issues warning on fecal transplant transmission of SARS-CoV-2
Covid ICYMI
Tribes Outperform Federal Government in COVID-19 Response
Covid ICYMI
FDA to allow alternative respiratory devices to treat COVID-19
Covid ICYMI
Week-old COVID-19 urology guidelines already outdated
Covid ICYMI